prednisolone has been researched along with Coronary Restenosis in 6 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Initial experiences with systemic administration of glucocorticoids after PCI failed to confirm the expected benefits of this treatment, probably as a result of inadequate dosage and pharmacokinetic calculations." | 2.44 | Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. ( Brunelleschi, S; Ferrero, V; Pesarini, G; Ribichini, F; Vassanelli, C, 2007) |
| "The cause was established to be metal allergy, as determined by patch tests which were strongly positive for bare metal stents and weakly positive for CoCr-EES." | 1.43 | Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis. ( Itoh, T; Morino, Y; Nakajima, Y, 2016) |
| "We describe a case of pneumonitis that developed 2 months after EES implantation for angina." | 1.39 | Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report. ( Homma, S; Ichikawa, A; Isobe, K; Kikuchi, N; Sakamoto, S; Sano, G; Satoh, K; Shibuya, K; Sugino, K; Takai, Y, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, Y | 1 |
| Itoh, T | 1 |
| Morino, Y | 1 |
| Adam, Z | 1 |
| Turley, A | 1 |
| Mason, JM | 1 |
| Kasim, AS | 1 |
| Newby, D | 1 |
| Mills, N | 1 |
| Padfield, G | 1 |
| Thompson, L | 1 |
| Morley, R | 1 |
| Hall, JA | 1 |
| Wright, RA | 1 |
| Muir, DF | 1 |
| Sutton, AG | 1 |
| Swanson, N | 1 |
| Carter, J | 1 |
| Bilous, R | 1 |
| Jones, S | 1 |
| de Belder, MA | 1 |
| Sakamoto, S | 1 |
| Kikuchi, N | 1 |
| Ichikawa, A | 1 |
| Sano, G | 1 |
| Satoh, K | 1 |
| Sugino, K | 1 |
| Isobe, K | 1 |
| Takai, Y | 1 |
| Shibuya, K | 1 |
| Homma, S | 1 |
| Kuchulakanti, P | 1 |
| Waksman, R | 1 |
| Grinius, V | 1 |
| Navickas, R | 1 |
| Unikas, R | 1 |
| Ferrero, V | 1 |
| Ribichini, F | 1 |
| Pesarini, G | 1 |
| Brunelleschi, S | 1 |
| Vassanelli, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical and Angiographic Outcome of Patients Treated With Bare Metal Stent (BMS) Implantation Compared With Drug Eluting Stents or BMS Plus Systemic Prednisone Therapy. A Randomized, Multicentre Study.[NCT00369356] | Phase 2/Phase 3 | 375 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for prednisolone and Coronary Restenosis
| Article | Year |
|---|---|
Therapeutic potential of oral antiproliferative agents in the prevention of coronary restenosis.
Topics: Administration, Oral; Anti-Inflammatory Agents; Coronary Restenosis; Humans; Hydroxymethylglutaryl-C | 2004 |
[Stents in interventional cardiology].
Topics: Aged; Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Anti-Inflammatory Agents; Aspirin; Clop | 2007 |
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential.
Topics: Angioplasty; Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Coronary Restenosis; Gluco | 2007 |
1 trial available for prednisolone and Coronary Restenosis
| Article | Year |
|---|---|
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention.
Topics: Acute Coronary Syndrome; Adrenal Cortex Hormones; Aged; Alloys; Chromium Alloys; Coronary Restenosis | 2016 |
2 other studies available for prednisolone and Coronary Restenosis
| Article | Year |
|---|---|
Metal allergy to everolimus-eluting cobalt chromium stents confirmed by positive skin testing as a cause of recurrent multivessel in-stent restenosis.
Topics: Anti-Allergic Agents; Cardiovascular Agents; Chromium Alloys; Coronary Angiography; Coronary Artery | 2016 |
Everolimus-induced pneumonitis after drug-eluting stent implantation: a case report.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Restenosis; Coronary Stenosis; Drug- | 2013 |